Pharmaceutical firms feel little threat of hostile M&A
Published: 2003-06-16 07:00:00
Updated: 2003-06-16 07:00:00
The shareholdings of major shareholders (including special representatives) in domestic listed pharmaceutical firms hovered at 10~30 percent and the majority of owner-chairmen regard their managerial control as stable, according to data compiled by Yakup Shinmoon.
By company, Yuyu Pharm's Chai...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
